Intravaginal drug delivery device
Patent 6103256 Issued on August 15, 2000. Estimated Expiration Date: 
December 2, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
December 2, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.InventorAssigneeApplicationNo. 452695 filed on 12/02/1999US Classes:424/430, Vaginal, urethral, uterine424/431, Tampon424/432, IUD or ring424/433Depot, pellet, matrix, or suppositoryExaminersPrimary: Azpuru, CarlosAttorney, Agent or FirmForeign Patent References
International ClassesA61F 006/06A61F 013/02 A61F 006/14 Foreign Application Priority Data1997-06-24 GBAbstractAn intravaginal drug delivery device comprising at least one active agent dispersed in a polymer matrix, wherein the concentration of active agent at the outer surface of the device at the time of use is not substantially higher than the concentration of the active agent in the remainder of the device, a method of treatment therewith and a process for its preparation. | |
